BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34001748)

  • 1. Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus-A Report of Two Cases.
    Yi LG; Gru AA
    Am J Dermatopathol; 2021 Dec; 43(12):e293-e297. PubMed ID: 34001748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
    Bakr F; Wain EM; Barlow R; Robson A
    Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Cutaneous CD4
    Maurelli M; Colato C; Gisondi P; Girolomoni G
    J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.
    Bakr F; Wain EM; Wong S; Palmer R; Robson A
    Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.
    Keeling BH; Gavino ACP; Admirand J; Soldano AC
    J Cutan Pathol; 2017 Nov; 44(11):944-947. PubMed ID: 28749588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
    Magro CM; Olson LC; Fulmer CG
    Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adnexotropism as a Histopathological Clue for the Diagnosis of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
    Pérez González YC; Llamas Velasco MDM; Díaz Recuero JL; Machan S; Núñez Hipolito L; Piris Pinilla MA; Rodríguez Pinilla SM
    Am J Dermatopathol; 2020 May; 42(5):383-384. PubMed ID: 31313694
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
    Salah E
    J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
    Leeolou MC; Young PA; Saleem A; Narala S; Bae GH
    Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound Appearance of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
    Rodríguez-Lomba E; Molina-López I; Pulido-Pérez A; Ciudad-Blanco C
    Actas Dermosifiliogr; 2017 Oct; 108(8):792-794. PubMed ID: 28388988
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis.
    Alexiades-Armenakas MR; Baldassano M; Bince B; Werth V; Bystryn JC; Kamino H; Soter NA; Franks AG
    Arthritis Rheum; 2003 Aug; 49(4):494-500. PubMed ID: 12910555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series.
    Surmanowicz P; Doherty S; Sivanand A; Parvinnejad N; Deschenes J; Schneider M; Hardin J; Gniadecki R
    Dermatology; 2021; 237(4):618-628. PubMed ID: 33326960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors.
    Sarac E; Demirkesen C
    An Bras Dermatol; 2023; 98(5):720-722. PubMed ID: 37225627
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal B-cell proliferations developing in the background of primary cutaneous CD4
    Ates Ozdemir D; Akdoğan N; Okay M; Uner A; Saglam A
    J Cutan Pathol; 2022 Nov; 49(11):971-977. PubMed ID: 35871674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Richter Syndrome Mimicking Primary Cutaneous CD4-Positive Small/Medium T-cell Lymphoma: Case Report and Review of the Literature.
    Rito M; Cabeçadas J; Costa Rosa J; Cravo M; Robson A
    Am J Dermatopathol; 2018 Apr; 40(4):286-290. PubMed ID: 28937430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic infiltration of the skin (Jessner): a T-cell lymphoproliferative disease.
    Willemze R; Dijkstra A; Meijer CJ
    Br J Dermatol; 1984 May; 110(5):523-9. PubMed ID: 6372848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
    Valentim FO; Oliveira CC; Miot HA
    An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal plasma cell infiltrates in the setting of cutaneous follicular helper T cell lymphoproliferative disorders.
    Magro CM; Ruan J; Grossman M; Hedayat AA
    Ann Diagn Pathol; 2019 Jun; 40():94-104. PubMed ID: 31077877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of tumid lupus erythematosus with systemic lupus erythematosus and discoid lupus erythematosus: a report of two cases of tumid lupus.
    Stead J; Headley C; Ioffreda M; Kovarik C; Werth V
    J Clin Rheumatol; 2008 Dec; 14(6):338-41. PubMed ID: 18664992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification.
    Kempf W; Kazakov DV; Cozzio A; Kamarashev J; Kerl K; Plaza T; Metze D
    Am J Dermatopathol; 2013 Apr; 35(2):159-66. PubMed ID: 22885550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.